130 related articles for article (PubMed ID: 15047125)
1. CD9 expression in gastric cancer and its significance.
Hori H; Yano S; Koufuji K; Takeda J; Shirouzu K
J Surg Res; 2004 Apr; 117(2):208-15. PubMed ID: 15047125
[TBL] [Abstract][Full Text] [Related]
2. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
[TBL] [Abstract][Full Text] [Related]
3. [Study on association between the expression of galectin- 3 and the peritoneal metastasis in gastric cancer].
Yang ZM; Wu XT; He T; Da MX; Luo T; Qian K
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Mar; 8(2):151-4. PubMed ID: 16155829
[TBL] [Abstract][Full Text] [Related]
4. Nuclear localization of annexin A1 correlates with advanced disease and peritoneal dissemination in patients with gastric carcinoma.
Zhu F; Xu C; Jiang Z; Jin M; Wang L; Zeng S; Teng L; Cao J
Anat Rec (Hoboken); 2010 Aug; 293(8):1310-4. PubMed ID: 20665809
[TBL] [Abstract][Full Text] [Related]
5. Oct4, a novel marker for human gastric cancer.
Chen Z; Xu WR; Qian H; Zhu W; Bu XF; Wang S; Yan YM; Mao F; Gu HB; Cao HL; Xu XJ
J Surg Oncol; 2009 Jun; 99(7):414-9. PubMed ID: 19347886
[TBL] [Abstract][Full Text] [Related]
6. [Expression of Ezrin in gastric carcinoma and its significance].
Shi RL; Li JF; Qu Y; Chen XH; Gu QL; Zhu ZG; Liu BY
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):433-5. PubMed ID: 17043968
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of CD9 expression in locally advanced gastric cancer treated with surgery and adjuvant chemoradiotherapy.
Soyuer S; Soyuer I; Unal D; Ucar K; Yildiz OG; Orhan O
Pathol Res Pract; 2010 Sep; 206(9):607-10. PubMed ID: 20547009
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
9. Ets-1 expression in gastric cancer.
Tsutsumi S; Kuwano H; Nagashima N; Shimura T; Mochiki E; Asao T
Hepatogastroenterology; 2005; 52(62):654-6. PubMed ID: 15816498
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of osteopontin expression in human gastric carcinoma.
Higashiyama M; Ito T; Tanaka E; Shimada Y
Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
[TBL] [Abstract][Full Text] [Related]
11. Wnt pathway is involved in advanced gastric carcinoma.
Zhang H; Xue Y
Hepatogastroenterology; 2008; 55(84):1126-30. PubMed ID: 18705344
[TBL] [Abstract][Full Text] [Related]
12. [Down-regulation of caveolin-1 in gastric carcinoma and its clinical biological significance].
Gao X; Sun Y; Huang L; Chen XY; Zhang KL; Kong QY; Liu J; Li H
Ai Zheng; 2005 Mar; 24(3):311-6. PubMed ID: 15757532
[TBL] [Abstract][Full Text] [Related]
13. [A comparative study of E-cadherin mRNA expression in primary tumors and metastatic foci of gastric cancer].
Yang J; Dai DQ
Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):25-8. PubMed ID: 15771793
[TBL] [Abstract][Full Text] [Related]
14. Loss of KAI1 expression in gastric cancer.
Tsutsumi S; Shimura T; Morinaga N; Mochiki E; Asao T; Kuwano H
Hepatogastroenterology; 2005; 52(61):281-4. PubMed ID: 15783050
[TBL] [Abstract][Full Text] [Related]
15. Motility related protein 1 (MRP1/CD9) expression in colon cancer.
Mori M; Mimori K; Shiraishi T; Haraguchi M; Ueo H; Barnard GF; Akiyoshi T
Clin Cancer Res; 1998 Jun; 4(6):1507-10. PubMed ID: 9626469
[TBL] [Abstract][Full Text] [Related]
16. [Expression of tumor marker CDw75 and its clinical impact in gastric carcinoma].
Li HX; Shen ZX; Tan SY
Ai Zheng; 2003 Jan; 22(1):83-5. PubMed ID: 12561443
[TBL] [Abstract][Full Text] [Related]
17. Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer.
Miyake M; Nakano K; Ieki Y; Adachi M; Huang CL; Itoi S; Koh T; Taki T
Cancer Res; 1995 Sep; 55(18):4127-31. PubMed ID: 7664290
[TBL] [Abstract][Full Text] [Related]
18. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR
J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications.
Wang JC; Bégin LR; Bérubé NG; Chevalier S; Aprikian AG; Gourdeau H; Chevrette M
Clin Cancer Res; 2007 Apr; 13(8):2354-61. PubMed ID: 17406028
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination: morphologic alteration and reduced expression of beta1 integrin subsets.
Furuya M; Kato H; Nishimura N; Ishiwata I; Ikeda H; Ito R; Yoshiki T; Ishikura H
Cancer Res; 2005 Apr; 65(7):2617-25. PubMed ID: 15805258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]